[{"address1": "680 East Colorado Boulevard", "address2": "Suite 180", "city": "Pasadena", "state": "CA", "zip": "91101", "country": "United States", "phone": "631 830 7092", "fax": "631 982 5050", "website": "https://lixte.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with Atezolizumab for patients with microsatellite stable metastatic colorectal cancer. The company's LB-100 combined with doxorubicin in advanced soft tissue sarcoma is under Phase 1b portion; and LB-100 combined with dostarlimab that is in phase 1b/2 for ovarian clear cell carcinoma. The company has a clinical trial research agreement with the Netherlands Cancer Institute; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; and a development collaboration agreement with the Netherlands Cancer Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Mr. Bastiaan  van der Baan M.Sc.", "age": 52, "title": "President, Chief Scientific Officer & Director", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 172784, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert Neal Weingarten", "age": 72, "title": "CFO, VP & Secretary", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 175000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Geordan G. Pursglove", "age": 36, "title": "CEO & Chairman", "yearBorn": 1988, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.97, "open": 3.98, "dayLow": 3.8142, "dayHigh": 4.88, "regularMarketPreviousClose": 3.97, "regularMarketOpen": 3.98, "regularMarketDayLow": 3.8142, "regularMarketDayHigh": 4.88, "payoutRatio": 0.0, "beta": 0.31, "volume": 286906, "regularMarketVolume": 286906, "averageVolume": 2083925, "averageVolume10days": 158220, "averageDailyVolume10Day": 158220, "bid": 4.69, "ask": 4.88, "bidSize": 1, "askSize": 1, "marketCap": 14742415, "fiftyTwoWeekLow": 0.64, "fiftyTwoWeekHigh": 4.88, "fiftyDayAverage": 2.2466, "twoHundredDayAverage": 1.8394, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 15186743, "profitMargins": 0.0, "floatShares": 2603605, "sharesOutstanding": 3027190, "sharesShort": 122174, "sharesShortPriorMonth": 4456, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.0404, "heldPercentInsiders": 0.18032, "heldPercentInstitutions": 0.11599, "shortRatio": 0.02, "shortPercentOfFloat": 0.040900003, "impliedSharesOutstanding": 3027190, "bookValue": -0.872, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -3324198, "trailingEps": -1.45, "lastSplitFactor": "1:10", "lastSplitDate": 1685923200, "52WeekChange": 1.2339449, "SandP52WeekChange": 0.20277917, "quoteType": "EQUITY", "currentPrice": 4.87, "recommendationKey": "none", "totalCash": 1384697, "totalCashPerShare": 0.516, "totalDebt": 0, "quickRatio": 3.899, "currentRatio": 4.264, "returnOnAssets": -0.81143, "returnOnEquity": -1.5513699, "freeCashflow": -1725609, "operatingCashflow": -2943794, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "LIXT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1754092393, "regularMarketTime": 1754078401, "exchange": "NCM", "messageBoardId": "finmb_29181356", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "postMarketChangePercent": -1.84804, "postMarketPrice": 4.78, "postMarketChange": -0.0899997, "regularMarketChange": 0.9, "regularMarketDayRange": "3.8142 - 4.88", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2083925, "fiftyTwoWeekLowChange": 4.23, "fiftyTwoWeekLowChangePercent": 6.609375, "fiftyTwoWeekRange": "0.64 - 4.88", "fiftyTwoWeekHighChange": -0.010000229, "fiftyTwoWeekHighChangePercent": -0.0020492272, "fiftyTwoWeekChangePercent": 123.394485, "dividendDate": 1605830400, "earningsTimestamp": 1747053000, "earningsTimestampStart": 1754510400, "earningsTimestampEnd": 1754942400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.45, "fiftyDayAverageChange": 2.6234, "fiftyDayAverageChangePercent": 1.1677202, "twoHundredDayAverageChange": 3.0305998, "twoHundredDayAverageChangePercent": 1.6476023, "priceToBook": -5.584862, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1193319000000, "shortName": "Lixte Biotechnology Holdings, I", "longName": "Lixte Biotechnology Holdings, Inc.", "regularMarketChangePercent": 22.67, "regularMarketPrice": 4.87, "cryptoTradeable": false, "displayName": "Lixte Biotechnology", "trailingPegRatio": null, "__fetch_time": "2025-08-02"}]